Announced 49 days laterFiled 26 September 2025
Angiex, Inc. has sold $22M so far
Angiex, Inc., a biotech company based in Cambridge, MA, has sold $22M so far in its equity round, according to a filing dated 26 September 2025.
Filed 49 days before it was announced on 14 November 2025. angiex.com ↗
- Filed
- 26 September 2025
- First filed
- 14 August 2025
- Round
- Equity round (amended filing)
- Amount sold
- $22M
- Offering size
- $28.4M
- Investors so far
- 137
- Based in
- Cambridge, MA
- Industry
- Biotech
- Website
- angiex.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 75% of the 1,404 tracked raises with an amount filed in 2025, and than 60% of the 112 in biotech.
Angiex, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 26 Sep 2025 | Amended filing | $22M | This raise |
| 14 Aug 2025 | New filing | $11M | This raise |
More with 82VS QP on the board
- Human Biotech, Inc.$10M
- Wheeler Bio, Inc.$23.1M
- Aakha Biologics, Inc.$750K
- Mytide Therapeutics, Inc.$1.16M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.